BioSyent Inc. (CVE:RX – Get Free Report) insider FAX Capital Corp. sold 500,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of C$10.05, for a total transaction of C$5,025,000.00.
BioSyent Price Performance
Shares of CVE:RX opened at C$10.85 on Friday. The company has a market capitalization of C$125.75 million, a PE ratio of 18.08 and a beta of 0.94. The company has a current ratio of 6.13, a quick ratio of 6.91 and a debt-to-equity ratio of 3.40. BioSyent Inc. has a twelve month low of C$7.66 and a twelve month high of C$11.45. The firm has a 50 day simple moving average of C$10.18 and a 200-day simple moving average of C$9.32.
About BioSyent
Read More
- Five stocks we like better than BioSyent
- Financial Services Stocks Investing
- Emerging Markets: What They Are and Why They Matter
- 3 Monster Growth Stocks to Buy Now
- Recession or Not, These 3 Stocks Are Winners
- What Are Some of the Best Large-Cap Stocks to Buy?
- Why NVIDIA Is More of a Screaming Buy Than Ever
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.